102
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Cisplatin as Second Line Chemotherapy in Advanced or Recurrent Squamous Cell Carcinoma of Head and Neck Region

Pages 357-359 | Accepted 05 May 1987, Published online: 08 Jul 2009

References

  • Davis S., Kessler W. Randomized comparison of cis-diaminedichloroplatinum versus cis-diaminedichloroplatinum, methotrexate and bleomycin in recurrent squamous cell carcinoma of the head and neck. Cancer Chemother. Pharmacol. 1979; 3: 57
  • Grose W. E., Lehane D. E., Dixon D. O., Fletcher W. S., Stuckey W. J. Comparison of methotrexate and cis-platin for patients with advanced squamous cell carcinoma of the head and neck region. A southwest oncology group study. Cancer Treat. Rep. 1977; 61: 359
  • Hong W. K., Schaefer S., Issel B., Coll. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer 1983; 52: 206
  • Jacobs C. High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer. Recent results. Cancer Res. 1981; 76: 290
  • Jacobs C, Bertino J. R., Goffinet D. R., Fee W. E., Goode R. L. 24-hour infusion of cis-platinum in head and neck cancers. Cancer 1978; 42: 2135
  • Jacobs C, Bertino J. R., Goffinet D. R., Fee W. E., Goode R. Cis-platinum chemotherapy in head and neck cancers. Otolaryngology 1978; 86: 780
  • Kish J. A., Weaver A., Jacobs J., Cummings G., Al-Sarraf M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984; 53: 1819
  • Sako S., Razack M. S., Kalnins I. Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diaminedichloropla-tinum. Amer. J. Surg. 1978; 136: 529
  • Schaefer S. D., Middleton R., Reish J., Frenkel E. P. Cis-platinum induction chemotherapy in the multi-modality initial treatment of advanced stage IV carcinoma of the head and neck. Cancer 1983; 51: 2168
  • Tranter R. M. D., Howell A. Cis-diaminedichloropla-tinutn (II) CDDP. Single agent in the treatment of advanced head and neck squamous cell carcinoma. J. Laryngol. Otol. 1983; 97: 177
  • Weaver A., Flemming S., Ensley J., Coll. Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer. Amer J. Surg. 1984; 148: 525
  • Weaver A., Flemming S., Ensley Kish J. J., Coll. Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer. Amer. J. Surg. 1982; 144: 445
  • WHO handbook for reporting results of cancer treatment. World Health Organization, Geneva 1979, WHO Offset Publication No. 48.
  • Wittes R. E., Cvitkovic E., Shah H., Gerold F. P., Strong E. W. Cis-dichlorodiamineplatinum (II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat. Rep. 1977; 61: 359
  • Wittes R. E., Cvitkovic E., Shah H., Gerold Heller F. P.K., Randolph V., Coll. Cis-dichlorodiamineplatinum (II)-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat. Rep. 1979; 63: 1533

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.